60 Degrees Pharma Reports Clinical, Molecular Results From First Five Completed Patients In Relapsing Babesiosis Expanded Access Study; All Five Completed Patients Report Clinical Improvement

Loading news article.

60 Degrees Pharma Reports Clinical, Molecular Results From First Five Completed Patients In Relapsing Babesiosis Expanded Access Study; All Five Completed Patients Report Clinical Improvement | WAPE

60 Degrees Pharma Reports Clinical, Molecular Results From First Five Completed Patients In Relapsing Babesiosis Expanded Access Study; All Five Completed Patients Report Clinical Improvement

Article summary

Related companies

Analyzed by WAPE AI.

Comments —